AKRO•benzinga•
Akero Therapeutics To Present Results From Phase 2b HARMONY Trial Investigating Efruxifermin In Patients With Pre-Cirrhotic NASH On Sept. 13
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 8, 2022 by benzinga